Stock & Company Details
Novo-Nordisk A/S $NVO
Price:
N/A
N/A
3.4B
$205B
52 Week High:
N/A
10 Day Average Volume:
N/A
1.74
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
NVO technical indicators
Latest Novo-Nordisk A/S (NVO) indicator readings as of 2026-08-28.
NVO's 14-day RSI is 44.0, in neutral territory. At $45.61 it is trading 1.7% below its 200-day moving average of $46.41, and below its 50-day average of $47.89. Price sits in the middle of its Bollinger Bands ($44.30 to $48.47). ADX reads 13.8, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Novo Nordisk (NVO) is a global healthcare leader focused on diabetes care, obesity treatments, and rare disease therapies. Headquartered in Denmark, the company develops innovative GLP-1 and insulin products that serve millions of patients worldwide. With strong growth driven by demand for weight-loss and metabolic treatments, NVO combines consistent revenue expansion, high margins, and significant investment in research and development.
Finance Bot
Ask your questions
Start by typing a question below.
